Sponsor or institution

Clinical trials and research at First Affiliated Hospital of Guangxi Medical University

• 13Clinical trials
• 1Country

Newest trials

All recruiting trials (13)

• Testing the 2022 Optic Neuritis Criteria in suspected cases of optic neuritis

  We’re trying to see if the 2022 criteria can correctly identify optic neuritis in patients with new or recent vision problems, including people with certain antibody types.

  Recruiting at 9 sites First Affiliated Hospital of Guangxi Medical University · Nanning, Guangxi and 8 other locations · NCT07623252

• Tenecteplase after non-contrast CT for unknown-onset stroke

  This study tests whether giving tenecteplase helps people with acute ischemic stroke whose onset time is unknown.

  Recruiting Phase 3 First Affiliated Hospital of Guangxi Medical University · Xiamen, Fujian and 14 other locations · NCT07475949

• Intravenous Tenecteplase in Very Old Adults with Acute Ischemic Stroke

  This study tests whether giving tenecteplase through a vein within 4.5 hours of stroke onset helps people 80 and older.

  Recruiting First Affiliated Hospital of Guangxi Medical University · Nanning, Guangxi · NCT07475936

• Becotatug vedotin plus sintilimab with chemoradiation for high-risk nasopharyngeal carcinoma

  This trial tests whether adding becotatug vedotin before treatment and giving sintilimab with chemoradiation helps people with high‑risk locally advanced nasopharyngeal carcinoma live longer and avoid recurrence.

  Recruiting Phase 3 First Affiliated Hospital of Guangxi Medical University · Nanning, Guangxi · NCT07459296

• Luspatercept plus low-dose thalidomide for adults with transfusion-dependent β-thalassemia

  This study tests whether adding low-dose thalidomide to luspatercept helps adults with transfusion-dependent β-thalassemia need fewer red blood cell transfusions.

  Recruiting at 8 sites Phase 2 First Affiliated Hospital of Guangxi Medical University · Shenzhen, Guangdong and 7 other locations · NCT07338344

• Treating clonorchiasis with albendazole, tribendimidine, or praziquantel in Guangxi

  We will test which of three medicines—albendazole, tribendimidine, or praziquantel—best clears liver fluke (Clonorchis sinensis) eggs from stool in adults with clonorchiasis and record side effects.

  Recruiting at 2 sites First Affiliated Hospital of Guangxi Medical University · Nanning, Guangxi and 1 other locations · NCT07074444

• Using a monoclonal antibody to prevent graft-versus-host disease in thalassemia patients after stem cell transplantation

  This study is testing if a new antibody can help prevent graft-versus-host disease in thalassemia patients who are receiving stem cell transplants.

  Recruiting at 5 sites Phase 2 First Affiliated Hospital of Guangxi Medical University · Maoming, Guangdong and 4 other locations · NCT06657391

• Effects of Tislelizumab with Chemotherapy in Advanced Rectal Cancer

  This study is testing if adding a new drug called Tislelizumab to chemotherapy can help people with advanced rectal cancer have better outcomes before surgery.

  Recruiting Phase 2 First Affiliated Hospital of Guangxi Medical University · Nanning, Guangxi · NCT06254521

• Using immunonutrition to reduce oral mucositis in nasopharyngeal carcinoma patients after treatment

  This study is testing if a special type of nutrition can help reduce painful mouth sores in patients with nasopharyngeal cancer who are getting treatment.

  Recruiting at 20 sites First Affiliated Hospital of Guangxi Medical University · Fuzhou, Fujian and 19 other locations · NCT05892354

• Evaluating a new gene therapy for transfusion-dependent beta-thalassemia

  This study is testing a new gene therapy to see if it can help people with transfusion-dependent beta-thalassemia reduce or stop their need for regular blood transfusions.

  Recruiting Early Phase 1 First Affiliated Hospital of Guangxi Medical University · Nanning, Guangxi · NCT05762510

• Evaluating GMCN-508A for treating transfusion-dependent α-thalassemia

  This study is testing a new treatment using a patient's own stem cells to see if it can help young people with transfusion-dependent α-thalassemia live healthier lives.

  Recruiting Phase 1 First Affiliated Hospital of Guangxi Medical University · Nanning, Guangxi · NCT05757245

• Using edaravone to treat optic neuritis

  This study is testing if edaravone can help improve vision in Chinese adults who have recently experienced optic neuritis and have a specific antibody in their system.

  Recruiting First Affiliated Hospital of Guangxi Medical University · Nanning · NCT05540262

• Combining tislelizumab with chemoradiotherapy for advanced cervical cancer treatment

  This study is testing if adding a new immune treatment called tislelizumab to standard chemotherapy and radiation can help people with advanced cervical cancer do better than just the usual treatment.

  Recruiting Phase 2 First Affiliated Hospital of Guangxi Medical University · Nanning, Guangxi · NCT05511623

Quick answers

How many clinical trials run by First Affiliated Hospital of Guangxi Medical University are recruiting right now?

13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 3: 2, Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →